,SARS-CoV-2

Qin Qin1, Xinyi Jiang1, Liyun Huo1

  • 1State Key Laboratory of Genetic Engineering, Shanghai Engineering Research Center of Industrial Microorganisms, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Fudan University, Shanghai, 200438, China.

PubMed
概括

我们开发了一种计算方法来设计多价值蛋白质药物,这些药物针对SARS-CoV-2尖端蛋白的多个部位,增强对像Omicron这样的变体的治疗功效.